UG1CA189822
Cooperative Agreement
Overview
Grant Description
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks (CRO)
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Springfield,
Missouri
658042241
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 07/31/19 to 07/31/25 and the total obligations have increased 1001% from $1,040,000 to $11,453,579.
Ozark Health Ventures was awarded
Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO)
Cooperative Agreement UG1CA189822
worth $11,453,579
from National Cancer Institute in August 2014 with work to be completed primarily in Springfield Missouri United States.
The grant
has a duration of 11 years and
was awarded through assistance program 93.399 Cancer Control.
The Cooperative Agreement was awarded through grant opportunity NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required).
Status
(Complete)
Last Modified 7/19/24
Period of Performance
8/1/14
Start Date
7/31/25
End Date
Funding Split
$11.5M
Federal Obligation
$0.0
Non-Federal Obligation
$11.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to UG1CA189822
Additional Detail
Award ID FAIN
UG1CA189822
SAI Number
UG1CA189822-2016163659
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
DZNEK4C3J4H5
Awardee CAGE
4WWN8
Performance District
MO-07
Senators
Joshua Hawley
Eric Schmitt
Eric Schmitt
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $9,053,955 | 100% |
Modified: 7/19/24